This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DAUGHADAY, W. H. Articles by YAN, H. Search for Related Content PubMed PubMed Citation Articles by DAUGHADAY, W. H. Articles by YAN, H.

Hypersomatotropism in Pregnant Women, as Measured by a Human Liver Radioreceptor Assay^*

Metabolism Division, Department of Medicine (W.H.D., B.T.), Y.), Washington University School of Medicine, St. Louis, Missouri 63110
The Division of Fetal Medicine, Department of Obstetrics and Gynecology (H.N. W., H. Y.), Washington University School of Medicine St. Louis, Missouri 63110

Address requests for reprints to: Dr. William H. Daughaday, Metabolism Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

Radioreceptor assays (RRAs) provide useful information about the bioactivity of peptide hormones. We have developed a RRA for human GH using membranes prepared from human liver. The assay has 1% cross-reactivity with human PRL, 0.11% cross-reactivity with human chorionic somatomammotropin, and negligible cross-reactivity with bovine and rat GH. The assay has distinct advantages over the IM-9 lymphocyte RRA in having reduced nonspecific interference from serum proteins and providing a uniform source of receptors which can be stored for long periods at –70 C. The coefficient of variation of the assay is 13%. In studies of 55 sera from short children with normal or elevated serum GH concentrations the mean ratio of RRA GH to immunoradiometric assayed GH was 1.28.

This assay provided important information about the total GH activity in pregnancy. There was a progressive rise in RRA GH during pregnancy, reaching 64.7 ± 2.5 (±SE) µg/L at term. This level is 2–3 times higher than suggested by earlier estimates made with monoclonal antibody RIAs for pituitary GH. At term the contributions to total GH activity of serum are less than 3% from the pituitary, 12% from human chorionic somatomammotropin reacting with the GH receptor, and 85% from placental GH. Despite this great increase in receptor-reactive GH, somatomedin activity by bioassay is reduced, and IGF-I, determined by RIA after acid-gel filtration, is minimally elevated.

^* This work was supported by NICHHD Program Project Grant HD-20805.

Received May 24, 1989.

This article has been cited by other articles:

				M. Ishikawa, S. Yokoya, K. Tachibana, Y. Hasegawa, T. Yasuda, E. Tokuhiro, Y. Hashimoto, and T. Tanaka Serum Levels of 20-Kilodalton Human Growth Hormone (GH) Are Parallel Those of 22-Kilodalton Human GH in Normal and Short Children J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 98 - 104. [Abstract] [Full Text]

				A. P. Cemeroglu, A. L. Barkan, G. B. Kletter, I. Z. Beitins, and C. M. Foster Changes in Serum Immunoreactive and Bioactive Growth Hormone Concentrations in Boys with Advancing Puberty and in Response to a 20-Hour Estradiol Infusion J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2166 - 2171. [Abstract] [Full Text] [PDF]